878 related articles for article (PubMed ID: 2175799)
21. Inhibition of human platelet aggregation by a novel S-nitrosothiol is abolished by haemoglobin and red blood cells in vitro: implications for anti-thrombotic therapy.
Megson IL; Sogo N; Mazzei FA; Butler AR; Walton JC; Webb DJ
Br J Pharmacol; 2000 Dec; 131(7):1391-8. PubMed ID: 11090112
[TBL] [Abstract][Full Text] [Related]
22. A redox-based mechanism for nitric oxide-induced inhibition of DNA synthesis in human vascular smooth muscle cells.
Bundy RE; Marczin N; Chester AH; Yacoub M
Br J Pharmacol; 2000 Apr; 129(7):1513-21. PubMed ID: 10742309
[TBL] [Abstract][Full Text] [Related]
23. The effects of thiol modulators on nitrergic nerve- and S-nitrosothiols-induced relaxation in duodenum.
Kıroğlu OE; Aydinoglu F; Oğülener N
J Basic Clin Physiol Pharmacol; 2013; 24(2):143-50. PubMed ID: 23412870
[TBL] [Abstract][Full Text] [Related]
24. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug.
Megson IL; Greig IR; Gray GA; Webb DJ; Butler AR
Br J Pharmacol; 1997 Dec; 122(8):1617-24. PubMed ID: 9422806
[TBL] [Abstract][Full Text] [Related]
25. Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione.
Askew SC; Butler AR; Flitney FW; Kemp GD; Megson IL
Bioorg Med Chem; 1995 Jan; 3(1):1-9. PubMed ID: 8612040
[TBL] [Abstract][Full Text] [Related]
26. S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.
Sogo N; Campanella C; Webb DJ; Megson IL
Br J Pharmacol; 2000 Nov; 131(6):1236-44. PubMed ID: 11082133
[TBL] [Abstract][Full Text] [Related]
27. Smooth muscle relaxing effects of NO, nitrosothiols and a nerve-induced relaxing factor released in guinea-pig colon.
Iversen HH; Gustafsson LE; Leone AM; Wiklund NP
Br J Pharmacol; 1994 Dec; 113(4):1088-92. PubMed ID: 7889258
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
[TBL] [Abstract][Full Text] [Related]
29. The relaxant properties in guinea pig airways of S-nitrosothiols.
Jansen A; Drazen J; Osborne JA; Brown R; Loscalzo J; Stamler JS
J Pharmacol Exp Ther; 1992 Apr; 261(1):154-60. PubMed ID: 1560360
[TBL] [Abstract][Full Text] [Related]
30. Nitrosothiol and nitrate tolerance.
Fung HL; Poliszczuk R
Z Kardiol; 1986; 75 Suppl 3():25-7. PubMed ID: 3099484
[TBL] [Abstract][Full Text] [Related]
31. Regulation of calcium-activated potassium channels by S-nitrosothiol compounds and cyclic guanosine monophosphate in rabbit coronary artery myocytes.
George MJ; Shibata EF
J Investig Med; 1995 Oct; 43(5):451-8. PubMed ID: 8528756
[TBL] [Abstract][Full Text] [Related]
32. Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro.
Gaston B; Drazen JM; Jansen A; Sugarbaker DA; Loscalzo J; Richards W; Stamler JS
J Pharmacol Exp Ther; 1994 Feb; 268(2):978-84. PubMed ID: 7906736
[TBL] [Abstract][Full Text] [Related]
33. A novel family of S-nitrosothiols: chemical synthesis and biological actions.
Al-Sa'doni HH; Khan IY; Poston L; Fisher I; Ferro A
Nitric Oxide; 2000 Dec; 4(6):550-60. PubMed ID: 11139363
[TBL] [Abstract][Full Text] [Related]
34. Electrochemical determination of S-nitrosothiols with a Clark-type nitric oxide electrode.
Pfeiffer S; Schrammel A; Schmidt K; Mayer B
Anal Biochem; 1998 Apr; 258(1):68-73. PubMed ID: 9527850
[TBL] [Abstract][Full Text] [Related]
35. Non-adrenergic, non-cholinergic relaxation of the bovine retractor penis muscle: role of S-nitrosothiols.
Liu X; Gillespie JS; Martin W
Br J Pharmacol; 1994 Apr; 111(4):1287-95. PubMed ID: 8032616
[TBL] [Abstract][Full Text] [Related]
36. Radiation sensitisation by nitric oxide releasing agents.
Mitchell JB; Cook JA; Krishna MC; DeGraff W; Gamson J; Fisher J; Christodoulou D; Wink DA
Br J Cancer Suppl; 1996 Jul; 27():S181-4. PubMed ID: 8763876
[TBL] [Abstract][Full Text] [Related]
37. Effects of the flavoprotein inhibitor, diphenyleneiodonium sulfate, on ex vivo organic nitrate tolerance in the rat.
Ratz JD; McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 2000 May; 293(2):569-77. PubMed ID: 10773030
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of SNAP potentiating antiproliferative effect of calcitonin gene-related peptide in cultured vascular smooth muscle cells.
Wang X; Wang W; Li Y; Bai Y; Fiscus RR
J Mol Cell Cardiol; 1999 Sep; 31(9):1599-606. PubMed ID: 10471344
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of nitric oxide release from S-nitrosothiols.
Singh RJ; Hogg N; Joseph J; Kalyanaraman B
J Biol Chem; 1996 Aug; 271(31):18596-603. PubMed ID: 8702510
[TBL] [Abstract][Full Text] [Related]
40. Interaction between endothelium-derived relaxing factors, S-nitrosothiols, and endothelin-1 on Ca2+ mobilization in rat vascular smooth muscle cells.
Okishio M; Ohkawa S; Ichimori Y; Kondo K
Biochem Biophys Res Commun; 1992 Mar; 183(2):849-55. PubMed ID: 1550591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]